Camden Capital, LLC
- SEC CIK
- 0001800752
- Latest filing
- Jul 28, 2026
EXAS holding history
Exact Sciences Corp in every 13F filed by Camden Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EXAS overviewAll 13F holders of EXASFull Q2 2026 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 0 | $0 | 0.0% | −2,685−100.0% | Sold out | Holders |
| Q2 2023 | 2,685 | $252.1K | <0.1% | −361−11.9% | Reduced | Holders |
| Q1 2023 | 3,046 | $206.5K | <0.1% | +3,046 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −3,196−100.0% | Sold out | Holders |
| Q1 2022 | 3,196 | $223.0K | <0.1% | +613+23.7% | Added | Holders |
| Q4 2021 | 2,583 | $201.0K | <0.1% | +323+14.3% | Added | Holders |
| Q3 2021 | 2,260 | $216.0K | <0.1% | +506+28.8% | Added | Holders |
| Q2 2021 | 1,754 | $218.0K | 0.1% | +122+7.5% | Added | Holders |
| Q1 2021 | 1,632 | $215.0K | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.